RANDOM PROSPECTIVE-STUDY OF VINDESINE VERSUS VINDESINE PLUS HIGH-DOSE CISPLATIN VERSUS VINDESINE PLUS CISPLATIN PLUS MITOMYCIN-C IN ADVANCED NON-SMALL-CELL LUNG-CANCER

被引：134
|
作者：
EINHORN, LH
LOEHRER, PJ
WILLIAMS, SD
MEYERS, S
GABRYS, T
NATTAN, SR
WOODBURN, R
DRASGA, R
SONGER, J
FISHER, W
STEPHENS, D
HUI, S
机构：
[1] INDIANA UNIV,SCH MED,DEPT MED,DIV HEMATOL ONCOL,INDIANAPOLIS,IN 46202
[2] PARKVIEW MEM HOSP,FT WAYNE,IN
[3] BULL MEM HOSP,MUNCIE,IN
[4] INDIANA UNIV,DEPT MED,BIOSTAT SECT,INDIANAPOLIS,IN 46204
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1986年 / 4卷 / 07期
关键词：
D O I：
10.1200/JCO.1986.4.7.1037
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1037 / 1043
页数：7
相关论文
共 50 条
  • [21] HIGH-DOSE MEDROXYPROGESTERONE ACETATE PLUS MITOMYCIN-C OR VINDESINE IN THE TREATMENT OF ADVANCED BREAST-CANCER
    FALKSON, CI
    FALKSON, HC
    FALKSON, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (04): : 431 - 434
  • [22] ECONOMIC-EVALUATION OF A RANDOMIZED CLINICAL-TRIAL COMPARING VINORELBINE, VINORELBINE PLUS CISPLATIN, AND VINDESINE PLUS CISPLATIN FOR NON-SMALL-CELL LUNG-CANCER
    SMITH, TJ
    HILLNER, BE
    NEIGHBORS, DM
    MCSORLEY, PA
    LECHEVALIER, T
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) : 2166 - 2173
  • [23] A RANDOMIZED TRIAL OF CISPLATIN AND VINDESINE VERSUS SUPPORTIVE CARE ONLY IN ADVANCED NON-SMALL-CELL LUNG-CANCER
    WOODS, RL
    WILLIAMS, CJ
    LEVI, J
    PAGE, J
    BELL, D
    BYRNE, M
    KERESTES, ZL
    BRITISH JOURNAL OF CANCER, 1990, 61 (04) : 608 - 611
  • [24] Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: The Japanese taxotere lung cancer study group
    Kubota, K
    Watanabe, K
    Kunitoh, H
    Noda, K
    Ichinose, Y
    Katakami, N
    Sugiura, T
    Kawahara, M
    Yokoyama, A
    Yokota, S
    Yoneda, S
    Matsui, K
    Kudo, S
    Shibuya, M
    Isobe, T
    Segawa, Y
    Nishiwaki, Y
    Ohashi, Y
    Niitani, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) : 254 - 261
  • [25] TRIAL OF THE COMBINATION OF MITOMYCIN, VINDESINE, AND CISPLATIN IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG-CANCER
    KRIS, MG
    GRALLA, RJ
    WERTHEIM, MS
    KELSEN, DP
    OCONNELL, JP
    BURKE, MT
    FIORE, JJ
    CIBAS, IR
    HEELAN, RT
    CANCER TREATMENT REPORTS, 1986, 70 (09): : 1091 - 1096
  • [26] VINDESINE AND MITOMYCIN-C IN INOPERABLE NON-SMALL CELL LUNG-CANCER
    MAIN, J
    CLARK, RA
    HUTCHEON, A
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (08): : 983 - 985
  • [27] PHASE-II STUDY OF CARBOPLATIN, CISPLATIN, AND VINDESINE IN ADVANCED NON-SMALL-CELL LUNG-CANCER
    SAITO, H
    SHIMOKATA, K
    SAKA, H
    YAMAMOTO, M
    OGASAWARA, T
    NOMURA, F
    SAKAI, S
    IWATA, M
    MURATE, T
    MIYACHI, T
    NAKASHIMA, K
    SAITO, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 33 (02) : 154 - 156
  • [28] PHASE II STUDY OF IFOSFAMIDE, CISPLATIN, AND VINDESINE COMBINATION IN ADVANCED NON-SMALL-CELL LUNG-CANCER
    OHNOSHI, T
    HIRAKI, S
    UEDA, N
    FUJII, M
    MACHIDA, K
    UEOKA, H
    KAWAHARA, S
    KOZUKA, A
    KIURA, K
    MORITAKA, T
    KODANI, T
    KAMEI, H
    KIMURA, I
    ACTA MEDICA OKAYAMA, 1991, 45 (05) : 357 - 361
  • [29] RANDOMIZED TRIAL COMPARING VINDESINE PLUS CISPLATIN WITH VINBLASTINE PLUS CISPLATIN IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER, WITH AN ANALYSIS OF METHODS OF RESPONSE ASSESSMENT
    KRIS, MG
    GRALLA, RJ
    KALMAN, LA
    KELSEN, DP
    CASPER, ES
    BURKE, MT
    GROSHEN, S
    CIBAS, IR
    BAGIN, R
    HEELAN, RT
    CANCER TREATMENT REPORTS, 1985, 69 (04): : 387 - 395
  • [30] EFFICACY OF CHEMOTHERAPY WITH CISPLATIN, VINDESINE AND MITOMYCIN IN NON-SMALL-CELL LUNG-CANCER, STAGE-III
    RIGGI, M
    RUFFIE, P
    LECHEVALIER, T
    MUNCK, JN
    CVITKOVIC, E
    OLIVEIRA, J
    ARMAND, JP
    BULLETIN DU CANCER, 1988, 75 (07) : 628 - 629
12345